OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST

Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BROWNLOW, MICHELLE K, SCHULTZ, LOREN D, WANG, XIN-MIN, BRYAN, JANINE T, JANSEN, KATHRIN U
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BROWNLOW, MICHELLE K
SCHULTZ, LOREN D
WANG, XIN-MIN
BRYAN, JANINE T
JANSEN, KATHRIN U
description Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections. L'invention concerne des molécules d'ADN codant la protéine de HPV58 L1. Elle concerne, plus particulièrement, des polynucléotides codant la protéine de HPV58 L1, lesdits polynucléotides présentant une optimisation au niveau du codon dans le but d'une expression à niveau élevé dans une cellule de levure. On peut utiliser ces molécules synthétiques afin de produire des particules semblables au virus HPV58 (VLP), ainsi que des vaccins et des compositions pharmaceutiques contenant ces VLP de HPV58. Ces vaccins exercent un effet immunoprophylactique efficace contre l'infection par papillomavirus par l'intermédiaire d'un anticorps de neutralisation et d'une immunité véhiculée par les cellules et ils sont également utiles pour traiter des infections existantes par HPV.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2543928C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2543928C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2543928C3</originalsourceid><addsrcrecordid>eNrjZNDyDwjx9PWMcnVRcI0ICHINDvb091Pwd1PwCAhTMLVQ8DFU8PRTiHR1DA7hYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzo5GpibGlkYWzsaEVQAApF4jaA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST</title><source>esp@cenet</source><creator>BROWNLOW, MICHELLE K ; SCHULTZ, LOREN D ; WANG, XIN-MIN ; BRYAN, JANINE T ; JANSEN, KATHRIN U</creator><creatorcontrib>BROWNLOW, MICHELLE K ; SCHULTZ, LOREN D ; WANG, XIN-MIN ; BRYAN, JANINE T ; JANSEN, KATHRIN U</creatorcontrib><description>Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections. L'invention concerne des molécules d'ADN codant la protéine de HPV58 L1. Elle concerne, plus particulièrement, des polynucléotides codant la protéine de HPV58 L1, lesdits polynucléotides présentant une optimisation au niveau du codon dans le but d'une expression à niveau élevé dans une cellule de levure. On peut utiliser ces molécules synthétiques afin de produire des particules semblables au virus HPV58 (VLP), ainsi que des vaccins et des compositions pharmaceutiques contenant ces VLP de HPV58. Ces vaccins exercent un effet immunoprophylactique efficace contre l'infection par papillomavirus par l'intermédiaire d'un anticorps de neutralisation et d'une immunité véhiculée par les cellules et ils sont également utiles pour traiter des infections existantes par HPV.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110405&amp;DB=EPODOC&amp;CC=CA&amp;NR=2543928C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110405&amp;DB=EPODOC&amp;CC=CA&amp;NR=2543928C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BROWNLOW, MICHELLE K</creatorcontrib><creatorcontrib>SCHULTZ, LOREN D</creatorcontrib><creatorcontrib>WANG, XIN-MIN</creatorcontrib><creatorcontrib>BRYAN, JANINE T</creatorcontrib><creatorcontrib>JANSEN, KATHRIN U</creatorcontrib><title>OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST</title><description>Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections. L'invention concerne des molécules d'ADN codant la protéine de HPV58 L1. Elle concerne, plus particulièrement, des polynucléotides codant la protéine de HPV58 L1, lesdits polynucléotides présentant une optimisation au niveau du codon dans le but d'une expression à niveau élevé dans une cellule de levure. On peut utiliser ces molécules synthétiques afin de produire des particules semblables au virus HPV58 (VLP), ainsi que des vaccins et des compositions pharmaceutiques contenant ces VLP de HPV58. Ces vaccins exercent un effet immunoprophylactique efficace contre l'infection par papillomavirus par l'intermédiaire d'un anticorps de neutralisation et d'une immunité véhiculée par les cellules et ils sont également utiles pour traiter des infections existantes par HPV.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDyDwjx9PWMcnVRcI0ICHINDvb091Pwd1PwCAhTMLVQ8DFU8PRTiHR1DA7hYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzo5GpibGlkYWzsaEVQAApF4jaA</recordid><startdate>20110405</startdate><enddate>20110405</enddate><creator>BROWNLOW, MICHELLE K</creator><creator>SCHULTZ, LOREN D</creator><creator>WANG, XIN-MIN</creator><creator>BRYAN, JANINE T</creator><creator>JANSEN, KATHRIN U</creator><scope>EVB</scope></search><sort><creationdate>20110405</creationdate><title>OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST</title><author>BROWNLOW, MICHELLE K ; SCHULTZ, LOREN D ; WANG, XIN-MIN ; BRYAN, JANINE T ; JANSEN, KATHRIN U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2543928C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BROWNLOW, MICHELLE K</creatorcontrib><creatorcontrib>SCHULTZ, LOREN D</creatorcontrib><creatorcontrib>WANG, XIN-MIN</creatorcontrib><creatorcontrib>BRYAN, JANINE T</creatorcontrib><creatorcontrib>JANSEN, KATHRIN U</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BROWNLOW, MICHELLE K</au><au>SCHULTZ, LOREN D</au><au>WANG, XIN-MIN</au><au>BRYAN, JANINE T</au><au>JANSEN, KATHRIN U</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST</title><date>2011-04-05</date><risdate>2011</risdate><abstract>Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections. L'invention concerne des molécules d'ADN codant la protéine de HPV58 L1. Elle concerne, plus particulièrement, des polynucléotides codant la protéine de HPV58 L1, lesdits polynucléotides présentant une optimisation au niveau du codon dans le but d'une expression à niveau élevé dans une cellule de levure. On peut utiliser ces molécules synthétiques afin de produire des particules semblables au virus HPV58 (VLP), ainsi que des vaccins et des compositions pharmaceutiques contenant ces VLP de HPV58. Ces vaccins exercent un effet immunoprophylactique efficace contre l'infection par papillomavirus par l'intermédiaire d'un anticorps de neutralisation et d'une immunité véhiculée par les cellules et ils sont également utiles pour traiter des infections existantes par HPV.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2543928C
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title OPTIMIZED EXPRESSION OF HPV 58 L1 IN YEAST
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T18%3A49%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BROWNLOW,%20MICHELLE%20K&rft.date=2011-04-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2543928C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true